Positive direct antiglobulin tests in cancer patients hospitalized with COVID-19: A brief report from India

Management of autoimmune haemolytic anaemia in low-to-middle income countries: current challenges and the way forward

“…Although little data are available on the epidemiology of AIHA in LMIC, 46 , 48 , 49 the real number of patients is quite high. By 2023, India would become the largest country in the world by population (1.43 billion inhabitants; Fig.…”

Discrepancies among studies reporting the prevalence of positive direct antiglobulin tests in the COVID‐19 patient population

“…

Multiple authors have recently analysed various immunohematologic findings in patients with coronavirus disease 2019 (COVID-19), some of which have shown highly disparate results (Table 1). [1][2][3][4][5][6] For example, Pandey et al recently published a description of the prevalence of direct antiglobulin test (DAT) positivity in patients admitted to the intensive care unit (ICU), showing that the DAT was positive in 17.3% (50/289) of their cohort. 1 They compared this to a DAT-positivity frequency of 46% (52/113) in a study of hospitalised patients with COVID-19 by Berzuini et al (which Pandey et al incorrectly referenced as 26%).

…”